Innoviva (INVA) Other financing activities (2015 - 2026)
Innoviva's Other financing activities came in at $94,000 for Q2 2026, up 291.7% from $24,000 a year earlier but down 40.5% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Other financing activities (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Innoviva reported Other financing activities of $304,000, up 137.5% year-over-year; for FY2025, it was $143,000, up 0.7% from FY2024.
- Other financing activities carries a five-year compound annual growth rate of -65.8% (FY2020 to FY2025).
- Going back by year, Other financing activities was $142,000 in FY2024 (+84.4%), $77,000 in FY2023 (-99.9%), $69.81 million in FY2022 (+17.4%) and $59.46 million in FY2021 (+95.1%).
- The five-year range for quarterly Other financing activities is $18,000 (Q3 2024) to $13.1 million (Q4 2021).
- Year-over-year, Other financing activities has increased for five consecutive quarters, with growth averaging 83.8% over the last six quarters.
- The fastest year-over-year change in Other financing activities over five years came in Q4 2021 (growth of 421.5%), and the weakest in Q2 2023 (a decline of 99.7%).
- Business Quant data shows INVA's Other financing activities at $158,000 (Q1 2026), $27,000 (Q4 2025) and $25,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Innoviva | 1.54 Bn | -750.13 Mn | 90.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94,000.00 |
| Mar 31, 2026 | 158,000.00 |
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 67,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Jun 30, 2022 | 9.55 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Dec 31, 2021 | 13.10 Mn |
| Sep 30, 2021 | 4.91 Mn |
| Jun 30, 2021 | 20.16 Mn |
| Mar 31, 2021 | 21.29 Mn |
| Dec 31, 2020 | 2.51 Mn |
| Jun 30, 2020 | 12.15 Mn |
API Access
Innoviva Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();